Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1174940
Sentiment: neutral
Topics: sec-filing, 8-k, financial-update
Related Tickers: ORGN
TL;DR
ORGN filed an 8-K on 8/11/25, likely with financial updates. Watch for details.
AI Summary
On August 11, 2025, Oragenics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant business occurrences. No specific financial figures or new events were detailed in the provided excerpt.
Why It Matters
This filing signals that Oragenics Inc. is providing updates to the SEC, which could include material information relevant to investors about the company's operations or financial health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, which typically contains routine disclosures and does not inherently signal high risk without further details on specific events.
Key Players & Entities
- Oragenics Inc. (company) — Registrant
- August 11, 2025 (date) — Date of earliest event reported
- 1990 Main Street Suite 750 Sarasota , FL 34236 (address) — Principal executive offices
FAQ
What specific "Other Events" are being reported by Oragenics Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported, only that this item is included in the filing.
What is the significance of the "Financial Statements and Exhibits" section in this filing?
This section indicates that Oragenics Inc. is providing updated financial statements or related exhibits to the SEC, which could contain important financial information.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on August 11, 2025.
What is Oragenics Inc.'s principal executive office address?
Oragenics Inc.'s principal executive office is located at 1990 Main Street Suite 750, Sarasota, FL 34236.
What is the SEC file number for Oragenics Inc.?
The SEC file number for Oragenics Inc. is 001-32188.
Filing Stats: 423 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-08-11 08:30:46
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 66KB
- 0001641172-25-022908.txt ( ) — 277KB
- ogen-20250811.xsd (EX-101.SCH) — 3KB
- ogen-20250811_lab.xml (EX-101.LAB) — 33KB
- ogen-20250811_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 11 th day of August 2025. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Executive Officer